Conditions: Multiple Myeloma Non-Hodgkin Lymphoma Hodgkin Disease
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 12
Healthy volunteers: no

Brief summary:
This is a phase II study to evaluate the efficacy and safety of TG-0054 combined with G-CSF in mobilizing hematopoietic stem cells in patients with multiple myeloma, non-Hodgkin lymphoma or Hodgkin disease.

Detailed description:

Arms:
arm 1: 1\. G-CSF: 10 μg/kg/day, administrated via SC injections from Day 1 to Day 8; 2. TG-0054: 3.14 mg/kg, administrated via 15-min IV infusion from Day 5 to Day 9 as needed to reach the target collection goal

Interventions: intervention 1: TG-0054 combined with G-CSF
Intervention descriptions: intervention 1: None

Protocol document: